| |
 |
This is the category page. Below are all of the research programs that are associated with it
- Cesarean Delivery -
WOUND COMPLICATIONS RATES AFTER CESAREAN SECTION WHEN COMPARING CLOSURE OF SKIN WITH STAPLES OR SUBCUTICULAR SUTURE (Investigator Initiated Protocol)
(2_20080102_118)
Participants will be randomized at time of cesarean delivery for staple or suture closure. Approximately two weeks following cesarean delivery, the PI will call all participants enrolled in the study to find out whether or not the patient had a wound complication and if so, to collect information on the type of complication and treatment required. Questions will also be asked such as participant’s satisfaction with the closure method.
- Cesarean Delivery:
Study Closed to Accrual:
A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF SEPRAFILM® ADHESION BARRIER TO REDUCE ADHESION FORMATION FOLLOWING CESAREAN DELIVERY.
(2_20080903_118)
Patients presenting at LVH will be reviewed for eligibility. Participants who agree to be part of the study will be placed into one of two groups, Group A or Group B. Group A will receive the study product, Seprafilm® prior to surgical closure; and Group B will receive routine surgical closure without the Seprafilm®.
- Chart Review Only -
MODE OF DELIVERY IN VERTEX PRETERM SINGLETONS: DOES IT MATTER? (INVESTIGATOR INITIATED)
(1_20090104_118)
This study is a retrospective chart review, cohort study to compare pregnancy outcomes of cephalic presenting preterm neonates delivered vaginally to those delivered by c-section with the primary outcome of neonatal mortality. Medical records will be reviewed for neonates and obstetric patients who delivered at LVH-CC between June 1, 1997 and June 1, 2007.
- HPV -
EXPLORATION OF THE PREVALENCE OF HPV KNOWLEDGE IN THE LEHIGH VALLEY (Investigator Initiated Protocol)
(2_20070417_118)
Patients presenting to one of the participating offices will be asked to participate in an anonymous, confidential survey about HPV. Participation is voluntary and consent will not be signed, the process will be completely anonymous.
- OB/GYN Labor & Delivery -
INDUCTION OF LABOR WITH OXYTOCIN: WHEN SHOULD OXYTOCIN BE HELD
(2_20080907_118)
This is a randomized study for participants having cesarean delivery. One group will follow an oxytocin protocol which is incremental until 5cm dilation and then maintained at the same level throughout labor; the second group will follow an oxytocin protocol, also incremental, but then discontinued once the cervix is 5cm.
- Prenatal Testing:
NON-INVASIVE FETAL GENETIC TESTING USING MATERNAL BLOOD SAMPLES
(1_20090503_118)
This is to test the mother’s blood to determine how accurate the results are for testing for Down syndrome or other abnormalities. This study will be offered to pregnant women who have already decided to undergo an invasive prenatal diagnostic test such as amniocentesis, CVS or fetal blood sampling. The blood will be taken from the pregnant mother and sent to the study lab and the results will be compared with the other test results.
|
|
